Zacks Research Issues Negative Outlook for Nutrien Earnings

Nutrien Ltd. (NYSE:NTR) – Equities researchers at Zacks Research reduced their Q3 2026 earnings per share estimates for shares of Nutrien in a research note issued on Friday, August 21st. Zacks Research analyst Team now forecasts that the company will post earnings of $0.78 per share for the quarter, down from their previous forecast of $0.92. The consensus estimate for Nutrien’s current full-year earnings is $4.95 per share. Zacks Research also issued estimates for Nutrien’s Q4 2026 earnings at $0.99 EPS, FY2026 earnings at $4.71 EPS, Q1 2027 earnings at $0.65 EPS, Q2 2027 earnings at $1.66 EPS, Q3 2027 earnings at $0.93 EPS, Q4 2027 earnings at $1.14 EPS, FY2027 earnings at $4.38 EPS, Q1 2028 earnings at $0.63 EPS, Q2 2028 earnings at $1.48 EPS and FY2028 earnings at $4.23 EPS.

Several other equities analysts have also weighed in on the stock. Canadian Imperial Bank of Commerce reaffirmed an “outperform” rating on shares of Nutrien in a research report on Monday, August 10th. Scotiabank raised shares of Nutrien from a “sector perform” rating to a “sector outperform” rating and set a $80.00 price objective for the company in a research report on Tuesday, June 30th. UBS Group reduced their target price on Nutrien from $67.00 to $65.00 and set a “sell” rating for the company in a research report on Monday, May 11th. Morgan Stanley decreased their price objective on Nutrien from $93.00 to $81.00 and set an “overweight” rating on the stock in a report on Tuesday, July 7th. Finally, Mizuho reduced their target price on shares of Nutrien from $77.00 to $75.00 and set a “neutral” rating on the stock in a research note on Tuesday, July 14th. Seventeen investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Nutrien presently has an average rating of “Moderate Buy” and a consensus target price of $81.58.

Nutrien Trading Down 0.6%

Nutrien stock opened at $73.17 on Friday. The company’s fifty day simple moving average is $67.12 and its 200-day simple moving average is $70.54. The company has a quick ratio of 0.86, a current ratio of 1.39 and a debt-to-equity ratio of 0.36. Nutrien has a 12 month low of $53.03 and a 12 month high of $85.36. The stock has a market cap of $35.00 billion, a P/E ratio of 14.81, a P/E/G ratio of 0.74 and a beta of 0.61.

Nutrien (NYSE:NTR) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $2.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.70 by ($0.09). The company had revenue of $10.81 billion during the quarter, compared to analysts’ expectations of $10.44 billion. Nutrien had a return on equity of 8.88% and a net margin of 8.44%.Nutrien’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same period last year, the company earned $2.65 earnings per share.

Nutrien Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 16th. Shareholders of record on Tuesday, September 29th will be issued a dividend of $0.55 per share. The ex-dividend date of this dividend is Tuesday, September 29th. This represents a $2.20 dividend on an annualized basis and a yield of 3.0%. Nutrien’s dividend payout ratio is currently 44.53%.

Institutional Investors Weigh In On Nutrien

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. CORDA Investment Management LLC. acquired a new stake in shares of Nutrien in the second quarter valued at approximately $33,209,000. Vanguard Group Inc. lifted its holdings in Nutrien by 2.2% during the 4th quarter. Vanguard Group Inc. now owns 22,463,277 shares of the company’s stock worth $1,386,546,000 after buying an additional 479,834 shares in the last quarter. Bryn Mawr Trust Advisors LLC bought a new position in Nutrien in the 2nd quarter valued at $8,363,000. Geode Capital Management LLC boosted its position in Nutrien by 6.8% in the 4th quarter. Geode Capital Management LLC now owns 4,833,284 shares of the company’s stock valued at $304,217,000 after buying an additional 309,025 shares during the last quarter. Finally, Oxbow Advisors LLC increased its stake in shares of Nutrien by 35.2% in the 4th quarter. Oxbow Advisors LLC now owns 142,981 shares of the company’s stock valued at $8,825,000 after buying an additional 37,246 shares during the period. Institutional investors and hedge funds own 63.10% of the company’s stock.

Nutrien Company Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.